These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11411822)

  • 21. Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
    Helfer B; Samara MT; Huhn M; Klupp E; Leucht C; Zhu Y; Engel RR; Leucht S
    Am J Psychiatry; 2016 Sep; 173(9):876-86. PubMed ID: 27282362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of the pharmacologic management of depression.
    J Clin Psychiatry; 2006 Mar; 67(3):478-89. PubMed ID: 16649837
    [No Abstract]   [Full Text] [Related]  

  • 25. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
    J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and poststroke depression.
    Sonis J
    Am J Psychiatry; 2004 Aug; 161(8):1506-7; author reply 1507-8. PubMed ID: 15285995
    [No Abstract]   [Full Text] [Related]  

  • 27. Qualms about balms: perspectives on antidepressants.
    Greenberg RP
    J Nerv Ment Dis; 2001 May; 189(5):296-8. PubMed ID: 11379972
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of atypical depression with cognitive therapy or phenelzine.
    Levitan RD
    Arch Gen Psychiatry; 2000 Nov; 57(11):1084; author reply 1084-5. PubMed ID: 11074875
    [No Abstract]   [Full Text] [Related]  

  • 29. Introduction: defining remission in patients treated with antidepressants.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 22():3-6. PubMed ID: 10634348
    [No Abstract]   [Full Text] [Related]  

  • 30. Placebo protects subjects from nonresponse: a paradox of power.
    Leon AC
    Arch Gen Psychiatry; 2000 Apr; 57(4):329-30. PubMed ID: 10768693
    [No Abstract]   [Full Text] [Related]  

  • 31. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman M; Mattia JI; Posternak MA
    Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in the older adult: the challenge of medical comorbidity.
    Schultz SK
    Am J Psychiatry; 2007 Jun; 164(6):847-8. PubMed ID: 17541038
    [No Abstract]   [Full Text] [Related]  

  • 34. Observational measurement of symptoms responsive to treatment of major depressive disorder in children and adolescents.
    Kaminer Y; Seifer R; Mastrian A
    J Nerv Ment Dis; 1992 Oct; 180(10):639-43. PubMed ID: 1402842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for falls during treatment of late-life depression.
    Joo JH; Lenze EJ; Mulsant BH; Begley AE; Weber EM; Stack JA; Mazumdar S; Reynolds CF; Pollock BG
    J Clin Psychiatry; 2002 Oct; 63(10):936-41. PubMed ID: 12416604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of major depression: is improvement enough?
    Ferrier IN
    J Clin Psychiatry; 1999; 60 Suppl 6():10-4. PubMed ID: 10235119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 38. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract]   [Full Text] [Related]  

  • 39. Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy.
    Dunbar GC
    Pharmacology; 1995 Sep; 51(3):137-44. PubMed ID: 7501698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selecting methodologies for the evaluation of differences in time to response between antidepressants.
    Montgomery SA; Bech P; Blier P; Möller HJ; Nierenberg AA; Pinder RM; Quitkin FM; Reimitz PE; Rosenbaum JF; Rush AJ; Stassen HH; Thase ME
    J Clin Psychiatry; 2002 Aug; 63(8):694-9. PubMed ID: 12197449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.